Order Article Reprints

Lumen D, Näkki S, Imlimthan S, Lambidis E, Sarparanta M, Xu W, Lehto V-P, Airaksinen AJ. Site-Specific ¹¹¹In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model. Pharmaceutics. 2019; 11(12):686. https://doi.org/10.3390/pharmaceutics11120686

Lumen, Dave, Simo Näkki, Surachet Imlimthan, Elisavet Lambidis, Mirkka Sarparanta, Wujun Xu, Vesa-Pekka Lehto, and Anu J. Airaksinen. 2019. "Site-Specific ¹¹¹In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model" Pharmaceutics 11, no. 12: 686. https://doi.org/10.3390/pharmaceutics11120686

Lumen, D., Näkki, S., Imlimthan, S., Lambidis, E., Sarparanta, M., Xu, W., Lehto, V.-P., & Airaksinen, A. J. (2019). Site-Specific ¹¹¹In-Radiolabeling of Dual-PEGylated Porous Silicon Nanoparticles and Their In Vivo Evaluation in Murine 4T1 Breast Cancer Model. Pharmaceutics, 11(12), 686. https://doi.org/10.3390/pharmaceutics11120686